Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × Valacyclovir × Clear all

NCT00492050 2026-03-11

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Phase 2 Active not recruiting

46 enrolled 10 charts

Waldenstrom Macroglobulinemia